Loading…

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

Recent studies have found the KIT D816V mutation in peripheral blood of virtually all adult systemic mastocytosis patients once highly sensitive PCR techniques were used; thus, detection of the KIT D816V mutation in peripheral blood has been proposed to be included in the diagnostic work-up of syste...

Full description

Saved in:
Bibliographic Details
Published in:Modern pathology 2015-08, Vol.28 (8), p.1138-1149
Main Authors: Jara-Acevedo, Maria, Teodosio, Cristina, Sanchez-Muñoz, Laura, Álvarez-Twose, Ivan, Mayado, Andrea, Caldas, Carolina, Matito, Almudena, Morgado, José M, Muñoz-González, Javier I, Escribano, Luis, Garcia-Montero, Andrés C, Orfao, Alberto
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent studies have found the KIT D816V mutation in peripheral blood of virtually all adult systemic mastocytosis patients once highly sensitive PCR techniques were used; thus, detection of the KIT D816V mutation in peripheral blood has been proposed to be included in the diagnostic work-up of systemic mastocytosis algorithms. However, the precise frequency of the mutation, the biological significance of peripheral blood-mutated cells and their potential association with involvement of bone marrow hematopoietic cells other than mast cells still remain to be investigated. Here, we determined the frequency of peripheral blood involvement by the KIT D816V mutation, as assessed by two highly sensitive PCR methods, and investigated its relationship with multilineage involvement of bone marrow hematopoiesis. Overall, our results confirmed the presence of the KIT D816V mutation in peripheral blood of most systemic mastocytosis cases (161/190; 85%)—with an increasing frequency from indolent systemic mastocytosis without skin lesions (29/44; 66%) to indolent systemic mastocytosis with skin involvement (124/135; 92%), and more aggressive disease subtypes (11/11; 100%)—as assessed by the allele-specific oligonucleotide-qPCR method, which was more sensitive ( P
ISSN:0893-3952
1530-0285
DOI:10.1038/modpathol.2015.72